On January 28, 2025, the Company received clearance of its IND from the FDA to initiate a first-in-human Phase 1 dose ...

Hair loss is such a common experience that many people go through, but it can seem like it hits us out of nowhere. There are ...

Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of ...

Last week the Edinburgh Cancer Centre begun treating prostate cancer patients within the framework of the so-called Precision Study. Patients receive only three radiation doses, with the Raypilot ...

Finding a hair-loss fix has required ongoing research and trials. As UCLA scientists target a promising treatment option, ...

Alopecia is the general medical term for hair loss, which can come in different forms and severities. Hair loss is a common ...

STRATA Skin Sciences (SSKN) announces the results of a newly published study in Japan that further validates the technological advantages of ...

It’s time that insurance recognizes wigs as necessary medical expenses for those suffering from conditions like alopecia, ...

The annual meeting of the American Academy of Dermatology was held from March 7 to 11 in Orlando, Florida, and attracted ...

Ivarmacitinib at both 4 mg and 8 mg doses was found to be efficacious in treating alopecia areata in a phase 3 trial.

Significantly more patients receiving baricitinib 2 mg, 4 mg had SALT score ≤20, ≤10 versus placebo at week 36 ...